Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2023 Jan 9.
Published in final edited form as: Contemp Clin Trials. 2016 Oct 8;51:97. doi: 10.1016/j.cct.2016.09.008

Corrigendum to “Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial.” [Contemp. Clin. Trials 49 (2016): 21–28]

Robert P Schwartz a,*, Sharon M Kelly a, Shannon G Mitchell a, Laura Dunlap b, Gary A Zarkin b, Anjalee Sharma a, Kevin E O’Grady c, Jerome H Jaffe a,d
PMCID: PMC9828321  NIHMSID: NIHMS1856766  PMID: 27729206

We mistakenly stated that the modified Composite International Diagnostic Interview 2 (CIDI-2) will be used to assess substance use disorders. However, we will actually use the modified World Mental Health-CIDI [WMH-CIDI] (http://www.hcp.med.harvard.edu/wmhcidi/index.php).

The heading on page 23 should read: 5.3 Modified World Mental Health Composite International Diagnostic Interview (WMH CIDI) for substance use disorders. The first sentence under that heading should read: “The WMH CIDI, an updated version of the CIDI-2 [30], was modified and used to determine whether individuals met the DSM-5 criteria for opioid and cocaine use disorders or remission in the 12 months prior to baseline and during the one-month period prior to the 3, 6, and 12 month study assessments.” In Table 1, modified CIDI-2 SAM = modified Composite International Diagnostic Interview 2 Substance Abuse Module should be replaced with modified WMH CIDI = Modified World Mental Health Composite International Diagnostic Interview.

RESOURCES